180 related articles for article (PubMed ID: 28767087)
1. Novel Methylselenoesters as Antiproliferative Agents.
Díaz-Argelich N; Encío I; Plano D; Fernandes AP; Palop JA; Sanmartín C
Molecules; 2017 Aug; 22(8):. PubMed ID: 28767087
[TBL] [Abstract][Full Text] [Related]
2. Novel selenadiazole derivatives as selective antitumor and radical scavenging agents.
Ruberte AC; Plano D; Encío I; Aydillo C; Sharma AK; Sanmartín C
Eur J Med Chem; 2018 Sep; 157():14-27. PubMed ID: 30071406
[TBL] [Abstract][Full Text] [Related]
3. Novel Methylselenoesters Induce Programed Cell Death via Entosis in Pancreatic Cancer Cells.
Khalkar P; Díaz-Argelich N; Antonio Palop J; Sanmartín C; Fernandes AP
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30241340
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of organoselenium (NSAIDs-SeCN and SeCF
He X; Zhong M; Li S; Li X; Li Y; Li Z; Gao Y; Ding F; Wen D; Lei Y; Zhang Y
Eur J Med Chem; 2020 Dec; 208():112864. PubMed ID: 32987314
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiproliferative activity of novel methylselenocarbamates.
Romano B; Font M; Encío I; Palop JA; Sanmartín C
Eur J Med Chem; 2014 Aug; 83():674-84. PubMed ID: 25014639
[TBL] [Abstract][Full Text] [Related]
6. In vitro radical scavenging and cytotoxic activities of novel hybrid selenocarbamates.
Romano B; Plano D; Encío I; Palop JA; Sanmartín C
Bioorg Med Chem; 2015 Apr; 23(8):1716-27. PubMed ID: 25792142
[TBL] [Abstract][Full Text] [Related]
7. Chalcogen containing heterocyclic scaffolds: New hybrids with antitumoral activity.
Alcolea V; Plano D; Encío I; Palop JA; Sharma AK; Sanmartín C
Eur J Med Chem; 2016 Nov; 123():407-418. PubMed ID: 27487570
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiproliferative activity of novel selenoester derivatives.
Domínguez-Álvarez E; Plano D; Font M; Calvo A; Prior C; Jacob C; Palop JA; Sanmartín C
Eur J Med Chem; 2014 Feb; 73():153-66. PubMed ID: 24389510
[TBL] [Abstract][Full Text] [Related]
9. New organoselenides (NSAIDs-Se derivatives) as potential anticancer agents: Synthesis, biological evaluation and in silico calculations.
He X; Nie Y; Zhong M; Li S; Li X; Guo Y; Liu Z; Gao Y; Ding F; Wen D; Zhang Y
Eur J Med Chem; 2021 Jun; 218():113384. PubMed ID: 33799070
[TBL] [Abstract][Full Text] [Related]
10. Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells.
Zheng X; Xu W; Sun R; Yin H; Dong C; Zeng H
Chem Biol Interact; 2017 Sep; 275():74-85. PubMed ID: 28757135
[TBL] [Abstract][Full Text] [Related]
11. A thioredoxin reductase inhibitor induces growth inhibition and apoptosis in five cultured human carcinoma cell lines.
Zhao F; Yan J; Deng S; Lan L; He F; Kuang B; Zeng H
Cancer Lett; 2006 May; 236(1):46-53. PubMed ID: 15982805
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of selenazolopyridine derivatives with capability to induce apoptosis in human breast carcinoma MCF-7 cells through scavenge of intracellular ROS.
Zhou M; Ji S; Wu Z; Li Y; Zheng W; Zhou H; Chen T
Eur J Med Chem; 2015; 96():92-7. PubMed ID: 25874334
[TBL] [Abstract][Full Text] [Related]
13. Novel seleno- and thio-urea derivatives with potent in vitro activities against several cancer cell lines.
Alcolea V; Plano D; Karelia DN; Palop JA; Amin S; Sanmartín C; Sharma AK
Eur J Med Chem; 2016 May; 113():134-44. PubMed ID: 26922233
[TBL] [Abstract][Full Text] [Related]
14. Persistent p21Cip1 induction mediates G(1) cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells.
Wang Z; Lee HJ; Chai Y; Hu H; Wang L; Zhang Y; Jiang C; Lü J
Curr Cancer Drug Targets; 2010 May; 10(3):307-18. PubMed ID: 20370687
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of thioredoxin reductase by a novel series of bis-1,2-benzisoselenazol-3(2H)-ones: Organoselenium compounds for cancer therapy.
He J; Li D; Xiong K; Ge Y; Jin H; Zhang G; Hong M; Tian Y; Yin J; Zeng H
Bioorg Med Chem; 2012 Jun; 20(12):3816-27. PubMed ID: 22579620
[TBL] [Abstract][Full Text] [Related]
16. Methylseleninic acid (MSA) inhibits 17β-estradiol-induced cell growth in breast cancer T47D cells via enhancement of the antioxidative thioredoxin/ thioredoxin reductase system.
Okuno T; Miura K; Sakazaki F; Nakamuro K; Ueno H
Biomed Res; 2012; 33(4):201-10. PubMed ID: 22975630
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro anticancer activities of some selenadiazole derivatives.
Plano D; Moreno E; Font M; Encío I; Palop JA; Sanmartín C
Arch Pharm (Weinheim); 2010 Nov; 343(11-12):680-91. PubMed ID: 21110339
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiproliferative activity of 17-[1',2',3']-selenadiazolylpregnenolone compounds.
Cui J; Pang L; Wei M; Gan C; Liu D; Yuan H; Huang Y
Steroids; 2018 Dec; 140():151-158. PubMed ID: 30296550
[TBL] [Abstract][Full Text] [Related]
19. Novel Dihydropyrimidinone-Derived Selenoesters as Potential Cytotoxic Agents to Human Hepatocellular Carcinoma: Molecular Docking and DNA Fragmentation.
Benassi JC; Barbosa FAR; Grinevicius VMAS; Ourique F; Coelho D; Felipe KB; Braga AL; Filho DW; Pedrosa RC
Anticancer Agents Med Chem; 2021; 21(6):703-715. PubMed ID: 32723262
[TBL] [Abstract][Full Text] [Related]
20. New Organoselenium (NSAIDs-Selenourea and Isoselenocyanate) Derivatives as Potential Antiproliferative Agents: Synthesis, Biological Evaluation and in Silico Calculations.
Nie Y; Li S; Lu Y; Zhong M; Li X; Zhang Y; He X
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
